J. William Langston

34.9k citations

268 papers · 24.4k indexed · 7 hit papers · h-index 76

Neurology top 0.01%
Cellular and Molecular Neuroscience top 0.05%
Molecular Biology top 1%
Neurology top 0.1%
Physiology top 0.5%

Co-authors: Ian Irwin James W. Tetrud Philip L. Ballard Lysia S. Forno Donato A. Di Monte Caroline M. Tanner Louis E. DeLanney Samuel M. Goldman
Topics: Parkinson's Disease Mechanisms and Treatments (129 papers)Neurological disorders and treatments (56 papers)Glioma Diagnosis and Treatment (41 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Canada Germany

In The Last Decade

J. William Langston

267 papers receiving 23.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 3.6k citations J. William Langston, James W. Tetrud et al. profile →
Rotenone, Paraquat, and Parkinson’s Disease

2011 1.1k citations Caroline M. Tanner, Samuel M. Goldman et al. Environmental Health Perspectives profile →
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1999 743 citations J. William Langston, Lysia S. Forno et al. Annals of Neurology profile →
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1984 740 citations J. William Langston, Lysia S. Forno et al. profile →
Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

2002 602 citations Alison L. McCormack, J. William Langston et al. Neurobiology of Disease profile →
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

2004 531 citations Lysia S. Forno, J. William Langston et al. Annals of Neurology profile →
Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1984 492 citations J. William Langston, Ian Irwin et al. profile →

Peers

Countries citing papers authored by J. William Langston

Since Specialization

Citations

This map shows the geographic impact of J. William Langston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. William Langston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. William Langston more than expected).

Fields of papers citing papers by J. William Langston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. William Langston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. William Langston. The network helps show where J. William Langston may publish in the future.

Co-authorship network of co-authors of J. William Langston

This figure shows the co-authorship network connecting the top 25 collaborators of J. William Langston. A scholar is included among the top collaborators of J. William Langston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. William Langston. J. William Langston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heart rate variability as a screening tool for Parkinson’s disease has age-dependent performance (P1.110) 2017 ·Neurology ·Michael Christiansen,(unknown),Joseph G. Hentz,Thomas G. Beach,Geidy E. Serrano,Holly A. Shill,Erika Driver‐Dunckley,Marwan N. Sabbagh,Kathryn A. Davis,J. William Langston,(unknown)	1
2	The MPTP Story 2017 ·Journal of Parkinson s Disease ·J. William Langston	285
3	Heart Rate Variability in LRRK2 Parkinson’s Disease (S37.004) 2014 ·Neurology ·Samuel M. Goldman,(unknown),Grace S. Bhudhikanok,(unknown),Monica Korell,(unknown),Chen Meng,Kathleen Comyns,Dolores D. Guest,Linda Rees,Seongseop Kim,Farah Kausar,(unknown),Emily Drabant Conley,Nicholas Eriksson,Grace Liang,Melanie Brandabur,James W. Tetrud,J. William Langston,Caroline M. Tanner	1
4	Parkinson's Disease Risk Is Associated with Variants in Genes That Bind Bacterial Cell-Wall Peptidoglycan (P05.051) 2013 ·Neurology ·Samuel M. Goldman,Sarah A. Jewell,Cheryl Meng,Web Ross,Anabel Chade,Meike Kasten,Grace S. Bhudhikanok,Kathleen Comyns,Monica Korell,J. William Langston,Caroline M. Tanner	1
5	LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction 2013 ·Neurobiology of Disease ·Laurie H. Sanders,Josée Laganière,Oliver Cooper,Sally K. Mak,(unknown),Ying Huang,David E. Paschon,(unknown),Ramya Sundararajan,Fyodor D. Urnov,J. William Langston,Philip D. Gregory,H. Steve Zhang,J. Timothy Greenamyre,Ole Isacson,Birgitt Schüle	216
6	Chronic Nicotine Treatment Increases nAChRs and Microglial Expression in Monkey Substantia Nigra After Nigrostriatal Damage 2009 ·Journal of Molecular Neuroscience ·Maryka Quik,Carla Cristian Campos,Neeraja Parameswaran,J. William Langston,J. Michael McIntosh,(unknown)	13
7	Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates 2006 ·Journal of Neurochemistry ·Maryka Quik,Neeraja Parameswaran,Sarah E. McCallum,Tanuja Bordia,(unknown),Alison L. McCormack,Amy Kim,Rachel F. Tyndale,J. William Langston,Donato A. Di Monte	100
8	Novel features in a patient homozygous for the L347P mutation in the PINK1 gene 2006 ·Parkinsonism & Related Disorders ·(unknown),James W. Tetrud,Martin Allen-Auerbach,J. William Langston,Birgitt Schüle	11
9	Accelerating Research on Genes and Environment in Parkinson?s Disease 2005 ·Environmental Health Perspectives ·J. William Langston	1
10	Enhanced striatal opioid receptor-mediated G-protein activation in l-dopa-treated dyskinetic monkeys 2005 ·Neuroscience ·(unknown),Daniel M. Togasaki,J. William Langston,Donato A. Di Monte,Maryka Quik	38
11	Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies 2002 ·American Journal Of Pathology ·Michael G. Schlossmacher,Matthew P. Frosch,Wei Gai,Miguel Medina,Nutan Sharma,Lysia S. Forno,Tomoyo Ochiishi,Hideki Shimura,Ronit Sharon,Nobutaka Hattori,J. William Langston,Yoshikuni Mizuno,Bradley T. Hyman,Dennis J. Selkoe,Kenneth S. Kosik	255
12	The hyperkinetic abnormal movements scale: A tool for measuring levodopa‐induced abnormal movements in squirrel monkeys 2002 ·Movement Disorders ·Louis C.S. Tan,(unknown),J. William Langston,Daniel M. Togasaki	17
13	Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial 2002 ·Annals of Neurology ·Ira Shoulson,David Oakes,Stanley Fahn,Anthony E. Lang,J. William Langston,Peter A. LeWitt,C. Warren Olanow,John B. Penney,Caroline M. Tanner,Karl Kieburtz,Alice Rudolph,(unknown)	200
14	Carboplatin is effective therapy for young children with progressiveoptic pathway tumors: A Pediatric Oncology Group phase II study 2000 ·Neuro-Oncology ·Donald H. Mahoney,Michael E. Cohen,Henry S. Friedman,James L. Kepner,(unknown),J. William Langston,Hector E. James,Patricia K. Duffner,Larry E. Kun	79
15	Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposurebreakdown → 1999 ·Annals of Neurology ·J. William Langston,Lysia S. Forno,James W. Tetrud,Alexander G. Reeves,Jordan Kaplan,(unknown)	743
16	Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements 1999 ·Magnetic Resonance Imaging ·R. Grant Steen,Wilburn E. Reddick,Robert J. Ogg,J. William Langston	2
17	PROTON MR SPECTROSCOPY OF PEDIATRIC BRAIN TUMORS 1998 ·Neuroimaging Clinics of North America ·June S. Taylor,Robert J. Ogg,J. William Langston	20
18	Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI 1998 ·Journal of Magnetic Resonance Imaging ·R. Grant Steen,Wilburn E. Reddick,Raymond K. Mulhern,J. William Langston,Robert J. Ogg,(unknown),Peter B. Kingsley,Winfred C. Wang	54
19	Production and disposition of 1‐methyl‐4‐phenylpyridinium in primary cultures of mouse astrocytes 1992 ·Glia ·Donato A. Di Monte,Ellen Y. Wu,Ian Irwin,Louis E. DeLanney,J. William Langston	18
20	Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents 1980 ·The Journal of Pediatrics ·Judith A. Wilimas,John R. Goff,(unknown),J. William Langston,Elizabeth Thompson	136

About J. William Langston

J. William Langston is a scholar working on Neurology, Genetics and Cellular and Molecular Neuroscience, having authored 268 papers that have together received 24.4k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (129 papers), Neurological disorders and treatments (56 papers) and Glioma Diagnosis and Treatment (41 papers). The work is most often cited by research in Neurology (14.4k citations), Cellular and Molecular Neuroscience (9.7k citations) and Neurology (3.2k citations). J. William Langston has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Ian Irwin, James W. Tetrud, Philip L. Ballard, Lysia S. Forno, Donato A. Di Monte, Caroline M. Tanner, Louis E. DeLanney, Samuel M. Goldman, Raymond K. Mulhern and Larry E. Kun. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact